Nasus Pharma Ltd Interest Expense Nonoperating
Nasus Pharma Ltd (NSRX) reported Interest Expense Nonoperating of -$78.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-03-25
| Period end | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 12 month |
|---|---|---|
| 2025-12-31 | -$78.00K 20-F · filed 2026-03-25 | |
| 2024-12-31 | $29.00K 20-F · filed 2026-03-25 | |
| 2024-06-30 | $18.00K 6-K · filed 2025-12-29 | |
| 2023-12-31 | $49.00K 20-F · filed 2026-03-25 |